Clinical Trial Update: Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya [Phase 4]

View source ↗

Summary

Phase 4 safety study of the Nasal Guide with Tyrvaya in dry eye and keratoconjunctivitis sicca completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Keratoconjunctivitis Sicca

Drugs mentioned

• Tyrvaya (varenicline)

Snippet

Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye, Keratoconjunctivitis Sicca | Phase 4 | Status: COMPLETED | Results posted: 2025-05-06